The Path From Heart Failure to Cardiac Transplant

Related Experiment Video

Updated: Mar 20, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

3.3K

Regi Freeman1, Erika Koerner, Courtney Clark

  • 1Samuel and Jean Frankel Cardiovascular Center, University of Michigan Health System, Ann Arbor (Mss Freeman, Koerner, Clark, and Halabicky); and University of Michigan School of Nursing, Ann Arbor (Mss Freeman and Halabicky).

Critical Care Nursing Quarterly
|June 3, 2016
PubMed

Insights

Heart failure treatments range from lifestyle changes to advanced therapies like cardiac transplant. This review details current heart failure management and cardiac transplant criteria.

Area of Science:

  • Cardiology
  • Transplant Surgery

Background:

  • Heart failure affects millions annually, presenting progressive symptoms.
  • Current treatments include lifestyle changes, medications, electrical therapies, and mechanical support.

Purpose of the Study:

  • To outline current heart failure treatments.
  • To detail cardiac transplant indications, contraindications, and evaluation.
  • To provide information on donor heart allocation and characteristics.

Main Methods:

  • Literature review of heart failure management strategies.
  • Analysis of current guidelines for cardiac transplantation.
  • Summary of donor heart selection and allocation processes.

Main Results:

  • A spectrum of treatments exists for heart failure, tailored to disease stage.
  • Cardiac transplant is the optimal treatment but limited by donor availability.
  • Specific criteria guide patient selection and donor heart allocation.

Conclusions:

  • Comprehensive management of heart failure involves diverse therapeutic options.
  • Cardiac transplantation offers a life-saving option for eligible patients.
  • Understanding transplant criteria and donor factors is crucial for successful outcomes.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.3K
A Modified Method for Heterotopic Mouse Heart Transplantion11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.3K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
594
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
727
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
514